Altre lingue Scholar Rock Holding Corporation

Azioni

SRRK

US80706P1030

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:02 18/04/2024			Variaz. 5gg	Var. 1 gen.
13,93 ^USD	+1,68%		-1,69%	-25,90%

28/03	Le azioni di Scholar Rock aumentano dopo l'avvio della copertura da parte di Raymond James	MT
28/03	SCHOLAR ROCK HOLDING CORPORATION : parere al rialzo da parte di Raymond James	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	15/04
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	12/04
Scholar Rock Shares Rise After Raymond James Initiates Coverage	28/03
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress	19/03
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
North American Morning Briefing : Investors -2-	18/03
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	15/03
North American Morning Briefing : Stock Futures -2-	11/03
Scholar Rock : Corporate Presentation March 2024	05/03
Scholar Rock to Participate in Upcoming Investor Conferences	28/02
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	16/02
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer	15/02
Scholar Rock Announces Management Appointments	15/02
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management	06/02
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management	06/02
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia	25/01
Scholar Rock Says FDA Clears Application for Trial of Obesity Treatment Apitegromab	23/01
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity	23/01
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity	23/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Scholar Rock Holding Corporation

Azioni

SRRK

US80706P1030

Altre lingue

Filtri